Global Breast Cancer Diagnostics Market Size
  • Published On: 25-03-2022

Global Breast Cancer Diagnostics Market Size

According to a new market research report published by Global Market Estimates, the Global Breast Cancer Diagnostics Market is projected to grow from USD 4.8 billion in 2021 and is expected to reach USD 7.5 billion by 2026 at a CAGR of 6.9% from 2021 to 2026. The growing awareness for breast cancer across the globe because of the increasing awareness campaigns by international organisations, increasing cases of breast cancer globally, growing diagnostics research activities due to increasing investments from the government as well as non-government sector are some of the key drivers of the growth experienced by the market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Breast Cancer Diagnostics Market - Forecast to 2026

Key Market Insights

·         Early detection of breast cancer can improve chances of survival. Growing demand for cancer diagnostics during routine check-ups is estimated to enhance the growth of the market

·         WHO estimates for 2021 portray breast cancer as the most common type of cancer with over 2.3 million new cases globally

·         The demand for the instrument-based segment is estimated to witness fast growth because of increasing technological innovation in the segment

·         The imaging segment in the market is predicted to be the largest shareholder because of ease of availability and increasing research for better services

·         F. Hoffmann-La Roche Ltd., Genomic Health, Hologic Inc., Danaher, Argon Medical Devices, Inc., BD, QIAGEN, Koninklijke Philips N.V., Myriad Genetics, and Thermo Fisher Scientific Inc., among others, are the major vendors in the breast cancer diagnostics market.

Product Outlook (Revenue, USD Billion, 2021-2026)

·         Instrument-based

o   Biopsy

o   Imaging

·         Platform-based

o   PCR

o   Next-generation Sequencing

o   Microarrays

o   Others

Type Outlook (Revenue, USD Billion, 2021-2026)

·         Blood Tests

·         Biopsy

·         Imaging

·         Genomic Tests

·         Others

Application Outlook (Revenue, USD Billion, 2021-2026)

·         Prognostic

·         Diagnostic & Predictive

·         Screening

·         Research

End-Use Outlook (Revenue, USD Billion, 2021-2026)

·         Diagnostic Centers & Medical Laboratories

·         Hospitals & Clinics

·         Others

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

  • The U.S.
  • Canada
  • Mexico


  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe 

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA


Contact: Yash Jain

Email address:

Phone Number: +16026667238